Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Sleep Wake Disorders 1Hematologic Neoplasms 1

Interventions

Cyclophosphamide 6fludarabine 4Standard of Care 4Practice Guidelines as Topic 3Mycophenolic Acid 3GSK2636771 3venetoclax 2trametinib 2talquetamab 2osimertinib 2dabrafenib 2X-Rays 2Whole-Body Irradiation 2Thiotepa 2Tacrolimus 2Specimen Handling 2Patient Navigation 2Methods 2Mesna 2Melphalan 2Magnetic Resonance Spectroscopy 2Filgrastim 2Educational Status 2Early Intervention, Educational 2Biopsy 2ulixertinib 1trastuzumab biosimilar HLX02 1thymoglobulin 1sapanisertib 1ruxolitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hematologic Neoplasms × Methylphenidate × 30 days × Clear all
NCT01628029 2026-05-22

Cognitive Behavioral Therapy and Multimodal Therapy in Treating Sleep Disturbance in Patients With Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
68 enrolled 16 charts
Other hematologic neoplasm

Sleep Wake Disorders, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡